These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

793 related articles for article (PubMed ID: 23974095)

  • 1. Nuclear reprogramming of luminal-like breast cancer cells generates Sox2-overexpressing cancer stem-like cellular states harboring transcriptional activation of the mTOR pathway.
    Corominas-Faja B; Cufí S; Oliveras-Ferraros C; Cuyàs E; López-Bonet E; Lupu R; Alarcón T; Vellon L; Iglesias JM; Leis O; Martín ÁG; Vazquez-Martin A; Menendez JA
    Cell Cycle; 2013 Sep; 12(18):3109-24. PubMed ID: 23974095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reprogramming of non-genomic estrogen signaling by the stemness factor SOX2 enhances the tumor-initiating capacity of breast cancer cells.
    Vazquez-Martin A; Cufí S; López-Bonet E; Corominas-Faja B; Cuyàs E; Vellon L; Iglesias JM; Leis O; Martín AG; Menendez JA
    Cell Cycle; 2013 Nov; 12(22):3471-7. PubMed ID: 24107627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of AMP-activated protein kinase (AMPK) provides a metabolic barrier to reprogramming somatic cells into stem cells.
    Vazquez-Martin A; Vellon L; Quirós PM; Cufí S; Ruiz de Galarreta E; Oliveras-Ferraros C; Martin AG; Martin-Castillo B; López-Otín C; Menendez JA
    Cell Cycle; 2012 Mar; 11(5):974-89. PubMed ID: 22333578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CXCR2 Ligands and mTOR Activation Enhance Reprogramming of Human Somatic Cells to Pluripotent Stem Cells.
    Lee SJ; Kang KW; Kim JH; Lee BH; Jung JH; Park Y; Hong SC; Kim BS
    Stem Cells Dev; 2020 Feb; 29(3):119-132. PubMed ID: 31808362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of cells with cancer stem cell properties from nontumorigenic human mammary epithelial cells by defined reprogramming factors.
    Nishi M; Sakai Y; Akutsu H; Nagashima Y; Quinn G; Masui S; Kimura H; Perrem K; Umezawa A; Yamamoto N; Lee SW; Ryo A
    Oncogene; 2014 Jan; 33(5):643-52. PubMed ID: 23318426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and in vitro characterisation of an induced pluripotent stem cell model of ovarian cancer.
    Bindhya S; Sidhanth C; Krishnapriya S; Garg M; Ganesan TS
    Int J Biochem Cell Biol; 2021 Sep; 138():106051. PubMed ID: 34343671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NKX3-1 is required for induced pluripotent stem cell reprogramming and can replace OCT4 in mouse and human iPSC induction.
    Mai T; Markov GJ; Brady JJ; Palla A; Zeng H; Sebastiano V; Blau HM
    Nat Cell Biol; 2018 Aug; 20(8):900-908. PubMed ID: 30013107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. OCT4 and SOX2 Work as Transcriptional Activators in Reprogramming Human Fibroblasts.
    Narayan S; Bryant G; Shah S; Berrozpe G; Ptashne M
    Cell Rep; 2017 Aug; 20(7):1585-1596. PubMed ID: 28813671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. OCT4 activity during conversion of human intermediately reprogrammed stem cells to iPSCs through mesenchymal-epithelial transition.
    Teshigawara R; Hirano K; Nagata S; Ainscough J; Tada T
    Development; 2016 Jan; 143(1):15-23. PubMed ID: 26657769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B Virus x Protein Increases Cellular OCT3/4 and MYC and Facilitates Cellular Reprogramming.
    Sanal MG; Gupta S; Saha R; Vats N; Sarin SK
    Cell Reprogram; 2023 Oct; 25(5):224-237. PubMed ID: 37769039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of Head and Neck Squamous Cancer Stem Cells by PI3K and SOX2.
    Keysar SB; Le PN; Miller B; Jackson BC; Eagles JR; Nieto C; Kim J; Tang B; Glogowska MJ; Morton JJ; Padilla-Just N; Gomez K; Warnock E; Reisinger J; Arcaroli JJ; Messersmith WA; Wakefield LM; Gao D; Tan AC; Serracino H; Vasiliou V; Roop DR; Wang XJ; Jimeno A
    J Natl Cancer Inst; 2017 Jan; 109(1):. PubMed ID: 27634934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gata4 blocks somatic cell reprogramming by directly repressing Nanog.
    Serrano F; Calatayud CF; Blazquez M; Torres J; Castell JV; Bort R
    Stem Cells; 2013 Jan; 31(1):71-82. PubMed ID: 23132827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced human somatic cell reprogramming efficiency by fusion of the MYC transactivation domain and OCT4.
    Wang L; Huang D; Huang C; Yin Y; Vali K; Zhang M; Tang Y
    Stem Cell Res; 2017 Dec; 25():88-97. PubMed ID: 29125994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MBD3 inhibits formation of liver cancer stem cells.
    Li R; He Q; Han S; Zhang M; Liu J; Su M; Wei S; Wang X; Shen L
    Oncotarget; 2017 Jan; 8(4):6067-6078. PubMed ID: 27894081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sox2 expression in breast tumours and activation in breast cancer stem cells.
    Leis O; Eguiara A; Lopez-Arribillaga E; Alberdi MJ; Hernandez-Garcia S; Elorriaga K; Pandiella A; Rezola R; Martin AG
    Oncogene; 2012 Mar; 31(11):1354-65. PubMed ID: 21822303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cleaved CD44 intracellular domain supports activation of stemness factors and promotes tumorigenesis of breast cancer.
    Cho Y; Lee HW; Kang HG; Kim HY; Kim SJ; Chun KH
    Oncotarget; 2015 Apr; 6(11):8709-21. PubMed ID: 25909162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knock out CD44 in reprogrammed liver cancer cell C3A increases CSCs stemness and promotes differentiation.
    Han S; Guo J; Liu Y; Zhang Z; He Q; Li P; Zhang M; Sun H; Li R; Li Y; Zeng W; Liu J; Lian L; Gao Y; Shen L
    Oncotarget; 2015 Dec; 6(42):44452-65. PubMed ID: 26540347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reprogramming Prostate Cancer Cells into Induced Pluripotent Stem Cells: a Promising Model of Prostate Cancer Stem Cell Research.
    Zhang Y; Chen B; Xu P; Liu C; Huang P
    Cell Reprogram; 2020 Oct; 22(5):262-268. PubMed ID: 32816532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HDAC6 differentially regulates autophagy in stem-like versus differentiated cancer cells.
    Sharif T; Martell E; Dai C; Ghassemi-Rad MS; Hanes MR; Murphy PJ; Margam NN; Parmar HB; Giacomantonio CA; Duncan R; Lee PWK; Gujar S
    Autophagy; 2019 Apr; 15(4):686-706. PubMed ID: 30444165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes miR-302 expression leading to self-renewal, clonal formation, and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinoma.
    Bourguignon LY; Wong G; Earle C; Chen L
    J Biol Chem; 2012 Sep; 287(39):32800-24. PubMed ID: 22847005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.